|
Volumn 16, Issue 2, 2005, Pages 279-284
|
Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
CORE PROTEIN;
HEPATITIS B ANTIBODY;
HEPATITIS B(E) ANTIGEN;
VIRUS DNA;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
GENE FREQUENCY;
GENETICS;
GENOTYPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
JAPAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TUMOR;
MALE;
MIDDLE AGED;
MUTATION;
PROMOTER REGION;
TIME;
TREATMENT OUTCOME;
ADULT;
ALANINE TRANSAMINASE;
CARCINOMA, HEPATOCELLULAR;
DNA, VIRAL;
FEMALE;
FOLLOW-UP STUDIES;
GENE FREQUENCY;
GENOTYPE;
HEPATITIS B ANTIBODIES;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
JAPAN;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
MUTATION;
PROMOTER REGIONS (GENETICS);
TIME FACTORS;
TREATMENT OUTCOME;
VIRAL CORE PROTEINS;
|
EID: 32944464763
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (33)
|
References (0)
|